Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SPOC Inc. (Stevens Proof of Concept)

This article was originally published in Start Up

Executive Summary

Low back pain affects 80% of Americans and is a leading cause of disability. Yet even though soft tissues including muscles are the primary source of this pain, many physicians neglect them and focus instead on spinal vertebrae, discs and nerves. And in cases where muscles are considered, pinpointing the exact muscle that causes the pain is extremely difficult with today's conventional diagnostic methods. The muscle pain detection device from SPOC Inc. (Stevens Proof of Concept) is noninvasive technology that uses electrical stimulation to diagnose muscle pain in any part of the body. The company believes its use will prevent many unnecessary spine surgeries that result in failed back surgery syndrome, which can occur in as many as 50% of cases.

You may also be interested in...



Start-Up Previews (06/2009)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Start-Ups Set Sights on Flu," features profiles of Alios BioPharma, Immune Targeting Systems, Marinomed Biotechnologie and Vivaldi Biosciences. Plus these Start-Ups Across Health Care: CardiAQ Valve Technologies, NKT THerapeutics, SPOC Inc.,and Sutro Biopharma.

Start-Up Previews (06/2009)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Start-Ups Set Sights on Flu," features profiles of Alios BioPharma, Immune Targeting Systems, Marinomed Biotechnologie and Vivaldi Biosciences. Plus these Start-Ups Across Health Care: CardiAQ Valve Technologies, NKT THerapeutics, SPOC Inc.,and Sutro Biopharma.

Is Spine Surgery Under Assault?

A recent article published in JAMA has spine surgeons crying foul. The article contends that spending on spine care increased 65% between 1997 and 2005--no big surprise given that healthc are spending in general increased by a similar amount over the same period. But an aggressive PR campaign behind the article seemed to single out surgery as a prime culprit in the rising costs and carried a clear message: that we're spending a lot on spine surgery and getting little in return. Moreover, claim surgeons, the article is just the latest in what they see as a larger campaing to cast doubts on the value of spine surgery and deny care to patients.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037611

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel